GSK combination migraine pill better than single therapy - Pharmaceutical Business Review
April 4, 2007 SpiritIndia | GSK combination migraine pill better than single therapy Pharmaceutical Business Review - Naproxen sodium is a non-steroidal anti-inflammatory drug (NSAID) and is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ... Trexima(TM) (Sumatriptan/Naproxen Sodium) Superior Efficacy Data ... |
Low-Dose Steroids Reduce Joint Damage Associated With Rheumatoid ... - About - News & Issues
April 4, 2007 About - News & Issues | Low-Dose Steroids Reduce Joint Damage Associated With Rheumatoid ... About - News & Issues, NY - ... associated with steroid therapy for rheumatoid arthritis requires further study, as does the usefulness of steroid treatment for rheumatoid arthritis ... |
First Approved Prefilled Autoinjector for Rheumatoid Arthritis and ... - PharmaLive.com (press release)
April 4, 2007| First Approved Prefilled Autoinjector for Rheumatoid Arthritis and ... PharmaLive.com (press release), PA - Early diagnosis and aggressive treatment of rheumatoid arthritis is critical to avoid the possibility of permanent disability and deformity.(9) ... |
Protemix Raises US$14.5 Million in First Close of Series A Financing - American Digital Networks (press release)
April 4, 2007| Protemix Raises US$14.5 Million in First Close of Series A Financing American Digital Networks (press release), MD - "This successful financing underscores the value of Protemix's technology and product candidates for the treatment of cardiovascular disease, diabetes and ... |
Protemix Raises US$14.5 Million in First Close of Series A Financing - American Venture Magazine (press release)
April 4, 2007| Protemix Raises US$14.5 Million in First Close of Series A Financing American Venture Magazine (press release), CA - "This successful financing underscores the value of Protemix's technology and product candidates for the treatment of cardiovascular disease, diabetes and ... |
Protemix Raises US$14.5 Million in First Close of Series A Financing - Business Wire (press release)
April 4, 2007| Protemix Raises US$14.5 Million in First Close of Series A Financing Business Wire (press release), CA - “This successful financing underscores the value of Protemix’s technology and product candidates for the treatment of cardiovascular disease, diabetes and ... |
First approved prefilled autoinjector for rheumatoid arthritis and ... - Canada NewsWire (press release)
April 4, 2007 NJBIZ | First approved prefilled autoinjector for rheumatoid arthritis and ... Canada NewsWire (press release), Canada - 8) Early diagnosis and aggressive treatment of rheumatoid arthritis is critical to avoid the possibility of permanent disability and deformity. ... Wyeth up on completing Japan unit buyout |